In about five months the patent for a key weight loss medication, semaglutide, will lapse in a large number of countries around the world including India, China, Brazil, and Canada although not in the most lucrative markets
They are not a lesser option, but a different route into clinically proven weight loss treatment
These include alterations in MEC II pyramidal cell projections to the hippocampal CA1 and cortical areas, as well as stellate cells targeting the dentate gyrus and CA3 regions, both of which are involved in memory and spatial navigation (Krishnan et al., 2025)
Key active ingredients include Akkermansia muciniphila Akk09, Lactobacillus acidophilus, Berberine HCL, and Decaffeinated Green Tea Extract
ZZ: Writing review & editing